This company has been marked as potentially delisted and may not be actively trading. Biora Therapeutics (BIOR) News Today Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsHeadlinesTrendsBuy This Stock BIOR Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Biora Therapeutics, Inc. (BIOR) - Yahoo FinanceAugust 25, 2025 | finance.yahoo.comBiora Therapeutics Stock Price History - Investing.comAugust 19, 2025 | investing.comBIORQ Biora Therapeutics, Inc.May 31, 2025 | seekingalpha.comBiora Therapeutics, Inc. (BIORQ)May 13, 2025 | ca.finance.yahoo.comTRexBio Expands Leadership Team with Appointments of Ariella Kelman, M.D., as Chief Medical Officer and Brandon Hants, MBA, as Chief Financial OfficerApril 8, 2025 | finance.yahoo.comBiora Therapeutics Successfully Completes Restructuring ProcessMarch 31, 2025 | markets.businessinsider.comNektar Therapeutics announces senior leadership changeFebruary 5, 2025 | msn.comFirm Retention Summary: Biora TherapeuticsJanuary 13, 2025 | wsj.comBiora Therapeutics undertakes Chapter 11 sales processDecember 31, 2024 | finance.yahoo.comBiora Therapeutics, Inc.: Biora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future GrowthDecember 30, 2024 | finanznachrichten.deBiora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future GrowthDecember 30, 2024 | markets.businessinsider.comBiora Therapeutics Files Voluntary Petition Under Chapter 11 - Quick FactsDecember 30, 2024 | markets.businessinsider.comWall Street Set to Open Flat Tuesday as Investors Await Inflation DataDecember 10, 2024 | msn.comBiora Therapeutics Faces Nasdaq Delisting ChallengesNovember 15, 2024 | markets.businessinsider.comBiora Therapeutics Reports Q3 2024 Results and UpdatesNovember 15, 2024 | markets.businessinsider.comBiora Therapeutics, Inc.: Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial ResultsNovember 14, 2024 | finanznachrichten.deBiora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial ResultsNovember 14, 2024 | markets.businessinsider.comBiora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial ResultsNovember 14, 2024 | globenewswire.comBiora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate UpdateNovember 7, 2024 | globenewswire.comBiora Therapeutics announces $3 million stock and warrant saleOctober 31, 2024 | investing.comBiora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesOctober 29, 2024 | globenewswire.comBiora shares progress on its development of BioJet Oral Delivery PlatformOctober 28, 2024 | markets.businessinsider.comBiora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD MeetingOctober 28, 2024 | globenewswire.comBiora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery MeetingOctober 14, 2024 | markets.businessinsider.comBiora Therapeutics (NASDAQ:BIOR) Stock, Short Interest ReportOctober 10, 2024 | benzinga.comBiora Therapeutics (NASDAQ:BIOR) Stock Quotes, Forecast and News SummaryOctober 10, 2024 | benzinga.comBiora Therapeutics to Present at the 19th Annual Peptide Therapeutics SymposiumOctober 7, 2024 | markets.businessinsider.comBiora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024September 30, 2024 | finance.yahoo.comBIOR Stock Earnings: Biora Therapeutics Beats EPS for Q1 2024September 23, 2024 | msn.comBiora Therapeutics Achieves ISO 13485 CertificationSeptember 9, 2024 | markets.businessinsider.comBiora Therapeutics Announces Positive Nasdaq Listing DecisionAugust 28, 2024 | markets.businessinsider.comBiora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment ConferenceAugust 26, 2024 | globenewswire.comBGLC Stock Earnings: BioNexus Gene Lab Reported Results for Q2 2024August 20, 2024 | markets.businessinsider.comBiora Therapeutics, Inc.: Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial ResultsAugust 18, 2024 | finanznachrichten.deBIOR: Second Quarter ResultsAugust 17, 2024 | finance.yahoo.comBiora Therapeutics Second Quarter 2024 Earnings: EPS: US$0.18 (vs US$1.47 loss in 2Q 2023)August 15, 2024 | uk.finance.yahoo.comQ2 2024 Biora Therapeutics Inc Earnings CallAugust 13, 2024 | finance.yahoo.comCrypto Project Essential Raises $11M for 'Intent-Based' BlockchainAugust 13, 2024 | msn.comBiora Therapeutics: Outperforming with Strong Q2 Financials and Clinical AdvancementsAugust 13, 2024 | markets.businessinsider.comBiora Therapeutics, Inc. (NASDAQ:BIOR) Q2 2024 Earnings Call TranscriptAugust 13, 2024 | msn.comBIOR Stock Earnings: Biora Therapeutics Beats EPS for Q2 2024August 12, 2024 | investorplace.comBiora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial ResultsAugust 12, 2024 | globenewswire.comBiora Therapeutics Announces Funding Agreement with Existing InvestorsAugust 12, 2024 | globenewswire.comBiora Therapeutics to Report Second Quarter 2024 Financial Results and Provide Corporate UpdateAugust 8, 2024 | globenewswire.comBiora Therapeutics to Participate in Canaccord Genuity 44th Annual Growth ConferenceAugust 6, 2024 | finance.yahoo.comBiora Therapeutics, Inc. (BIOR)July 26, 2024 | finance.yahoo.comBiora Therapeutics Buy Rating Confirmed by Positive Phase 1 Trial Outcomes and NaviCap Technology PotentialJuly 22, 2024 | markets.businessinsider.comBiora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL EventJuly 19, 2024 | markets.businessinsider.comBiora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit 2024June 11, 2024 | globenewswire.comBiora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024May 20, 2024 | globenewswire.com Get Biora Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BIOR Media Mentions By Week BIOR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIOR News Sentiment▼0.001.03▲Average Medical News Sentiment BIOR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIOR Articles This Week▼10▲BIOR Articles Average Week Get the Latest News and Ratings for BIOR and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Biora Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Galmed Pharmaceuticals News Today Can-Fite BioPharma News Today SciSparc News Today Universe Pharmaceuticals News Today Avenue Therapeutics News Today Akanda News Today Scinai Immunotherapeutics News Today Vaccinex News Today Evofem Biosciences News Today ZyVersa Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIOR) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biora Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access